Migræne kliniske forsøg i Alabama
5 studier for Migræne søger deltagere på steder i Alabama.
Byer i Alabama
Officiel studietekst (engelsk)
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Rehabilitation and Neurological Services /ID# 270782, Huntsville
RekruttererFase 3
Alder 12 til 17 · Alle køn · Opdateret 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- University of Alabama at Birmingham Children's of Alabama, Birmingham
Rekrutterer
Alder 10 til 17 · Alle køn · Opdateret 21. sep. 2026 · NCT05889624Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Rehabilitation & Neurological Services /ID# 229969, Huntsville
- The Center for Clinical Trials - Saraland /ID# 231546, Saraland
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Central Research Associates, LLC (CRA) dba Flourish Research, Birmingham
- AMR Mobile, Mobile
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- Flourish - Birmingham, Birmingham
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 19. maj 2026 · NCT06602479Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.